Canna Hemp’s Chris Rebentisch Speaks to Audience of Medical Professionals at Cedars-Sinai Cannabis Investing News
Lexaria Bioscience Corp. Receives New U.S. Patent Allowance for “Composition of Matter” Cannabinoid Delivery Cannabis Investing News
MedReleaf Issues Response to Health Canada’s Proposals on Cannabis Regulation Cannabis Investing News
